Financière Delpharm

Delpharm is a leading European Contract Development and Manufacturing Organization (CDMO) that provides comprehensive outsourcing solutions for the pharmaceutical industry. The company specializes in the development and industrial manufacture of a wide array of dosage forms, including solids, liquids, semi-solids, and sterile injectables. With a robust network of over 15 manufacturing sites across Europe and North America, Delpharm serves major global pharmaceutical companies as well as smaller biotech firms. The company has significantly expanded its capabilities into biologics and vaccine production, notably contributing to the fill-finish manufacturing of COVID-19 vaccines for global distribution.